Important Safety Information: GLP-1 receptor agonists carry a Boxed Warning for risk of thyroid C-cell tumors. Do not use if you or a family member has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you are pregnant, planning pregnancy within two months, or breastfeeding. Not for use in patients under 18. See full Important Safety Information and your medication's FDA Medication Guide. To report side effects, contact your care team or the FDA at fda.gov/medwatch or 1-800-FDA-1088. If this is a medical emergency, call 911.
* Compounded medications are not FDA-approved. They are prepared by licensed compounding pharmacies under the supervision of healthcare providers. These formulations may differ in safety, effectiveness, and quality from FDA-approved products. Only a licensed provider can determine whether a compounded medication is appropriate for an individual patient. Statements on this website have not been evaluated by the Food and Drug Administration. Compounded medications are not intended to diagnose, treat, cure, or prevent any disease. †Results may vary. Medication prescriptions are at the discretion of medical providers and may not be suitable for everyone. Consult a healthcare professional before using any medications or starting any weight loss program. Medication (when prescribed) is included in the cost of the Journey program. Medical treatment is provided and supervised by licensed healthcare professionals. Certain images and videos on this website may contain or consist entirely of AI-generated or AI-enhanced depictions. These synthetic visuals are created using advanced artificial intelligence and may not represent authentic, unaltered content.
© 2026 Journey. All rights reserved.
Journey does not provide medical advice. A prescription is never guaranteed.